Open AccessPHENYLPROPANOIDS, EUGENOL SCAFFOLD, AND ITS DERIVATIVES AS ANTICANCER
Author(s) -
Fadilah Fadilah,
Arry Yanuar,
Ade Arsianti,
Retnosari Andrajati
Publication year - 2017
Publication title -
asian journal of pharmaceutical and clinical research
Language(s) - English
Resource type - Journals
eISSN - 2455-3891
pISSN - 0974-2441
DOI - 10.22159/ajpcr.2017.v10i3.16071
Subject(s) - eugenol , chemistry , scaffold , guaiacol , cancer cell , pharmacology , cancer , biochemistry , biology , medicine , organic chemistry , biomedical engineering , genetics , catalysis
Eugenol (EU) is a phenylpropene, an allyl chain-substituted guaiacol. EU is a member of the phenylpropanoids class of chemical compounds. It is acolorless to pale yellow oily liquid extracted from certain essential oils especially from clove oil. Further, chemopreventive agents might be used singlyor in combination with chemotherapy or radiotherapy for the more effective treatment of cancer by enhancing the efficacy of these modalities withminimal side effects and toxicity. Considering that EU scaffold may be a prospective chemopreventive agent, its potent antitumor ability to interferewith solid cancer cell growth and its molecular mechanism were evaluated as an initiative toward the development of a novel strategy for cancertreatment. This review article will conduct that EU as the antiproliferative activity and molecular mechanism of the EU induced apoptosis against thecancer cells and animal models.Keywords: Eugenol, Derivatives of eugenol, Scaffold, Anticancer, Phenylpropanoids.